WebAug 23, 2024 · MEDIA CONTACT: INVESTOR CONTACT: Bill Berry Berry & Company Public Relations Phone: 212-253-8881 Email: [email protected] Andrew Funderburk Kendall Investor Relations WebSynlogic Therapeutics is a Business Services, Biotechnology Research, and Drug Manufacturing & Research company located in Cambridge, Massachusetts with $2.00 …
Synlogic - Overview, News & Competitors ZoomInfo.com
WebAug 11, 2024 · Ginkgo Bioworks. Aug 11, 2024, 07:05 ET. SYNB2081 is the second clinical drug candidate developed through the partnership between Ginkgo and Synlogic. … WebSep 6, 2024 · CAMBRIDGE, Mass., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today ... 20磅行距是多少倍行距word
sitchfi.com Technology Profile
WebChief Financial Officer at Synlogic . Michael Jensen serves as the Chief Financial Officer. He joined Synlogic in March 2024, overseeing finance, tax, accounting, treasury, and investor … WebAug 11, 2024 · Synlogic has also developed two drug candidates through a research collaboration with Ginkgo Bioworks: SYNB1353, designed to consume methionine for the potential treatment of HCU, and SYNB2081, designed to lower uric acid for the potential treatment of gout. For additional information visit www.synlogictx.com. WebApr 4, 2024 · Vincent Isabella is a Director - Head of Synthetic Biology at Synlogic based in Cambridge, Massachusetts. Previously, Vincent was a Senior Scienti st at AstraZeneca and also held positions at Academy of Medicine, University of Rochester Medical Center, The University of Rochester. Vincent received a Bachelor of Science degree from Rochester … 20社会主义现代化